- cafead Sep 21, 2022 at 08:22: PM
via After back-to-back setbacks in its high-stakes Gilenya patent defense, Novartis is taking its arguments all the way to the Supreme Court.
Wednesday, Novartis said it plans to petition the Supreme Court to take up the case after the U.S. Court of Appeals for the Federal Circuit rejected its bid to rehear the case.
article source
Wednesday, Novartis said it plans to petition the Supreme Court to take up the case after the U.S. Court of Appeals for the Federal Circuit rejected its bid to rehear the case.
article source